Bibliografía del artículo
1. Dyck JB, Dyck PJ. Diabetic polyneuropathy. In: Dyck PJ, Thomas PK, eds. Diabetic neuropathy, 2nd ed. Philadelphia, PA, W.B. Saunders Company, pp. 255-278, 1999.
2. Tentolouris N. Diabetic neuropathy. In: Katsilambros N, ed. Diabetes in clinical practice: Questions and answers from case studies. Chichester: John Wiley and Sons Ltd, pp. 187-199, 2006.
3. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47:1343-53, 2004.
4. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 43:957-73, 2000.
5. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928-44, 2001.
6. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 29:S4-S42, 2006.
7. Zick R, Schäper T, Deeters U. Peripheral diabetic neuropathy [in German]. Klinikarzt 32:192-4, 2003.
8. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26:1553-79, 2003.
9. Boulton AJM, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association (Position Statement). Diabetes Care 4:956-62, 2005.
10. Quattrini C, Jeziorska M, Malik RA. Small fibre neuropathy in diabetes: clinical consequence and assessment. Int J Low Extrem Wounds 3:16-21, 2004.
11. Papanas N, Giassakis G, Papatheodorou K et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 21:353-8, 2007.
12. Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJ, Malik RA. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia 51:1046-50, 2008.
13. Tentolouris N, Achtsidis V, Marinou K, Katsilambros N. Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 31:236-7, 2008.
14. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fibre neuropathy by sudomotor testing. Muscle Nerve 34:57-61, 2006.
15. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11:592-7, 1988.
16. Liatis S, Marinou K, Tentolouris N, Pagoni S, Katsilambros N. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med 24:1375-80, 2007.
17. Singer W, Spies JM, McArthur J et al. Prospective evaluation of somatic and autonomic small fibres in selected autonomic neuropathies. Neurology 62:612-8, 2004.
18. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care 22:598-602, 1999.
19. Kamei N, Yamane K, Nakanishi S et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 19:47-53, 2005.
20. Papanas N, Papatheodorou K, Christakidis D et al. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 113:195-8, 2005.
21. Kennedy WR, Navarro X. Sympathetic sudomotor function in diabetic neuropathy. Arch Neurol 46:1182-6, 1989.
22. Hoeldtke RD, Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GR. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 50:436-43, 2001.
23. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp Clin Endocrinol Diabetes 2005;113:577-81, .
24. Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes 116:135-8, 2008.
25. Spallone V, Morganti R, Siampli M et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med 26:686-92, 2009.
26. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21:1071-5, 1998.
27. Papanas N, Giassakis G, Papatheodorou K et al. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 115:58-61, 2007.
28. Tentolouris N, Pagoni S, Tzonou A, Katsilambros N. Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus. Eur J Intern Med 12:20-7, 2001.
29. Flynn MD, O'Brien IA, Corrall RJ. The prevalence of autonomic and peripheral neuropathy in insulin-treated diabetic subjects. Diabet Med 12:310-3, 1995.
30. Bilen H, Atmaca A, Akcay G. Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes. Adv Ther 24:1020-7, 2007.
31. Tentolouris N, Voulgari C, Liatis S, Kokkinos A, Eleftheriadou I, Makrilakis K, Marinou K, Katsilambros N. The moisture status of the skin of the feet assessed by the visual test Neuropad correlates with foot ulceration in diabetes. Diabetes Care 2010.
32. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 26:302-305, 2009.
33. Ambrosini Nobili L, Civitelli A, Campi F, Tedeschi A, Rizzo L, Piaggesi A. Neuropad is effective as first-line screening tool for the ulcerative risk of the diabetic foot. Oral Presentation No 50. 5th International Symposium on the Diabetic Foot, 9-12 May 2007.